ArticleClinics (Sao Paulo, Brazil)2026

Real-world 12-month outcomes of Risdiplam in spinal muscular atrophy types 2 and 3: A Brazilian cohort.

Clara Gontijo Camelo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.